Babafemi Olapoju Taiwo MD

Gene Stollerman Professor in Medicine-Infectious Diseases Chief, Infectious Diseases Division Northwestern University Medical School

Join to View Full Profile

676 N Saint Clair StChicago, IL 60611
Phone+1 312-926-8358
Fax+1 312-926-9630

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Infectious Disease, 2005 - 2007
Berkshire Medical CenterResidency, Internal Medicine, 1993 - 1997
University of IbadanClass of 1990

Certifications & Licensure

IL State Medical License 2005 - 2026
NC State Medical License 1996 - 2006

Clinical Trials

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 Start of enrollment: 2010 May 01
Completed
Phase 2
FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir Start of enrollment: 2013 Apr 25
Completed
Phase 4
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection Start of enrollment: 2014 May 30
Completed
Phase 1
Modulation of Immune Activation by Aspirin Start of enrollment: 2014 Aug 01
Completed
Phase 2
Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure Start of enrollment: 2014 Dec 01
Completed
Phase 3
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) Start of enrollment: 2015 Dec 21
Completed
Phase 1, Phase 2
PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332) Start of enrollment: 2017 Mar 14
COMPLETED
PHASE3
Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1 Start of enrollment: 2019 Dec 31
COMPLETED
PHASE2
A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV Start of enrollment: 2023 May 30
COMPLETED
PHASE2
Roles: Contact
Combination Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria Start of enrollment: 2024 Nov 28
RECRUITING
NA
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults with HIV-1: ACTG A5357.
Babafemi O Taiwo, Yu Zheng, Katherine Rodriguez, Leah Burke, Jacqueline D Reeves
Clinical Infectious Diseases. 2025-07-15
Patterns, Barriers and Facilitators of Responsiveness to Text Message Medication Reminders Among Youth Living with HIV in Southwest Nigeria.
Mobolanle Balogun, Aniekan E Ulor, Mayowa Odofin, Olufunmilola Idowu, Mmeli V Chukwu
Tropical Medicine and Infectious Disease. 2025-05-17
Risk Factors for Viral Non-suppression Among Youth Living with HIV in Nigeria: Findings from the iCARE Nigeria Study.
Mobolanle Balogun, Lisa M Kuhns, Alani S Akanmu, Robert Garofalo, Titilope Badru
AIDS and Behavior. 2025-03-01

Press Mentions

Cultivating Africa’s Research EnterpriseOctober 28th, 2021
Novel Polyclonal Antibody Therapy Meets the Criteria for Graduation to Phase 3 in ACTIV-2 TrialSeptember 28th, 2021
Northwestern Seeking 5,000 Volunteers for COVID-19 Prevention TrialsJuly 28th, 2020
Join now to see all

Babafemi Olapoju Taiwo MD

Dr. Taiwo is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.